Keros Therapeutics Inc (KROS)

SBC to Revenue

0.00%

Quarterly · Period ending:

KROS logo

KROS SBC to Revenue

Latest reported0.00%
KROS Quarterly SBC/Revenue (0.44% → 0.00%)
High-resolution chart · PNG

KROS sbc to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc SBC to Revenue — Quarterly
Period endingSBC to Revenue
0%
1,689.1008%
1,897.4026%
27.9484%
47.0167%
4.1956%
302.4326%
2,272.4227%
23,743.2432%
9,722.8916%
5,121.6783%
108,887.5%
0%
0%
0%
0%
0%
0%
16.475%
0%
2,849%
0%
0%
0%
0%
0%
0.72%
0.68%
0.52%
0.44%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.